Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04935229
Title Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors TriSalus Life Sciences, Inc.
Indications

uveal melanoma

Therapies

Ipilimumab + Nivolumab + SD-101

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.